Pilaralisib, CAS [[934526-89-3]]

Produktübersicht

• Artikelname: Pilaralisib, CAS [[934526-89-3]]
• Artikelnummer: TGM-T2365
• Hersteller Artikelnummer: T2365
• Alternativnummer: TGM-T2365-1ML, TGM-T2365-2MG, TGM-T2365-5MG, TGM-T2365-10MG, TGM-T2365-25MG, TGM-T2365-50MG, TGM-T2365-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Pilaralisib (XL-147) is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast

Produkteigenschaften

• Molekulargewicht: 541.02
• CAS Nummer: [934526-89-3]
• Formel: C25H25ClN6O4S
• Target-Kategorie: SAR245408 , XL-147